Literature DB >> 6326555

Computed tomography of the chest in small cell lung cancer: potential new prognostic signs.

N O Whitley, J Z Fuks, E S McCrea, M Whitacre, J A Masler, J E Whitley, J Aisner.   

Abstract

Computed tomography (CT) of the chest was performed as part of the initial and subsequent staging evaluations in 33 patients with small cell lung carcinoma. In 25 of the 33 patients, CT demonstrated findings not observed on standard radiography. Eleven of the 33 would have been staged higher using CT. Before treatment, CT revealed more mediastinal and nodal involvement than conventional films. After chemotherapy, CT demonstrated areas of residual or early recurrent disease in nine of 28 patients that were not apparent on chest films. Initially thickened pericardium in patients with limited disease and persistent bronchial narrowing after chemotherapy were demonstrated to be associated with early relapse in the chest and short survival. These initial data suggest that the CT scan, in addition to more accurately assessing the extent of disease, can provide a new risk classification for early chest relapse. Initial thickened pericardium in limited disease and continued bronchial narrowing after chemotherapy may allow patient selection for future treatment trials with radiation as an adjuvant to chemotherapy.

Entities:  

Mesh:

Year:  1984        PMID: 6326555     DOI: 10.2214/ajr.142.5.885

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  CT findings of small cell lung carcinoma: Can recognizable features be found?

Authors:  Dongjun Lee; Ji Young Rho; Seunghun Kang; Koun Joy Yoo; Hye Jeong Choi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 2.  The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging.

Authors:  Abbas Yousefi-Koma; Mojgan Panah-Moghaddam; Victor Kalff
Journal:  Tanaffos       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.